Clinical Trials Browser

Phase 3 × Standard of Care × Plasma cell × Clear all

NCT07181239 2025-09-18

Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients

Phase 3 Not yet recruiting

Multiple Myeloma